Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas

1996 ◽  
Vol 29 (6) ◽  
pp. 497-505 ◽  
Author(s):  
K. SAITOH ◽  
H. TAKAHASHI ◽  
M. YAMAMOTO ◽  
H. KISHI ◽  
P.G. PARSONS
1996 ◽  
Vol 71 ◽  
pp. 75
Author(s):  
Jun Mukai ◽  
Satoshi Shiojima ◽  
Yasuhito Shimada ◽  
Hiroshi Ohashi. ◽  
Satoshi Matsushima ◽  
...  

1997 ◽  
Vol 24 (3) ◽  
pp. 151-156 ◽  
Author(s):  
Jean Kanitakis ◽  
Sylvie Euvrard ◽  
Dominique Bourchany ◽  
Michel Faure ◽  
Alain Claudy

Oncogene ◽  
2003 ◽  
Vol 22 (30) ◽  
pp. 4617-4626 ◽  
Author(s):  
Takahisa Takino ◽  
Naohiko Koshikawa ◽  
Hisashi Miyamori ◽  
Motohiro Tanaka ◽  
Takuma Sasaki ◽  
...  

2009 ◽  
Vol 126 (1) ◽  
pp. 114-124 ◽  
Author(s):  
Soeren Torge Mees ◽  
Wolf Arif Mardin ◽  
Claudia Wendel ◽  
Nicole Baeumer ◽  
Edith Willscher ◽  
...  

2019 ◽  
Vol 39 (5) ◽  
Author(s):  
Qian Zhang ◽  
Jin-yan Wang ◽  
Wei Yan ◽  
Dan-dan Wang ◽  
Su-jin Yang ◽  
...  

Abstract Homo sapiens ceramide synthase 2 (CerS-2) plays an important role in inhibiting invasion and metastasis of tumor cells and has been reported as a tumor metastasis suppressor gene in diverse cancers. Thus, low level of CerS-2 protein might suggest a bad prognosis and up-regulation of CerS-2 protein might act as a promising therapeutic strategy for malignant tumors. In this review, we discussed the expression, as well as the clinical and pathological significance of CerS-2 in diverse human cancers. The pathological processes and molecular pathways regulated by CerS-2 were also summarized.


Sign in / Sign up

Export Citation Format

Share Document